Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-656-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin Sensitisation (read-across from structurally similar substance)
Negative (LLNA), OECD 429, EU Method B.42, Bradshaw (2009).
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- between 05 February 2009 and 18 February 2009.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in compliance with GLP and agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of relevant results.
- Remarks:
- Study conducted on read-across material
- Justification for type of information:
- A RAAF report will shortly be provided.
- Reason / purpose for cross-reference:
- other: read-across target
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Date of Signature: 15/10/2007; Date of Inspection: 21/08/2007
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Female CBA/Ca (CBA/CaOlaHsd) strain mice were supplied by Harlan Laboratories UK Limited, Bicester, Oxon, UK and female CBA/Ca (CBA/CaBkl) strain mice were supplied by B & K Universal Ltd, Hull, UK.
- Age at study initiation: eight to twelve weeks old.
- Weight at study initiation: At the start of the study the animals were in the weight range of 15 to 23 g
- Housing: The animals were individually housed in suspended solid floor polypropylene cages furnished with softwood woodflakes
- Diet : Teklad Global Rodent diet supplied by Harlan Teklad, Blackthorn, Bicester, Oxon, UK) was allowed throughout the study. ad libitum
- Water: Free access to mains tap water ( ad libitum)
- Acclimation period: acclimatisation period of at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): in the range 19 to 25°C
- Humidity (%): in the range 30 to 70%,
- Air changes (per hr): The rate of air exchange was approximately fifteen changes per hour
- Photoperiod (hrs dark / hrs light): twelve hours continuous light (06.00 to 18.00) and twelve hours darkness.
IN-LIFE DATES: From: Day 0 To: Day 6 - Vehicle:
- other: 1% pluronic L92 in distilled water,
- Concentration:
- 10%, 5% or 2.5% w/w in 1% pluronic L92 in distilled water.
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: Not stated in report
- Irritation: None
- Lymph node proliferation response:
The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (disintegrations per minute/node) and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Method B42 Skin Sensitisation (Local Lymph Node Assay) of Commission Directive 2004/73/EC
- Criteria used to consider a positive response:
The test material will be regarded as a sensitiser if at least one concentration of the test material results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test material failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non sensitiser".
TREATMENT PREPARATION AND ADMINISTRATION:
The mice were treated by daily application of 25 µl of the appropriate concentration of the test material to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test material formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette.
A further group of four mice received the vehicle alone in the same manner.
3H-Methyl Thymidine Administration:
Five days following the first topical application of the test material (Day 6) all mice were injected via the tail vein with 250 µl of phosphate buffered saline (PBS) containing 3H methyl thymidine (3HTdR: 80 µCi/ml, specific activity 2.0 Ci/mmol, GE Healthcare UK Ltd) giving a total of 20 µCi to each mouse. - Positive control substance(s):
- other: 2,4-Dinitrobenzenesulfonic acid, sodium salt
- Statistics:
- Not stated in report
- Positive control results:
- The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (% w/w) in
1% pluronic L92 in distilled water Stimulation Index Result
10 13.71 Positive
Conclusion: 2,4 Dinitrobenzenesulfonic acid, sodium salt was considered to be a sensitiser under the conditions of the test. - Key result
- Parameter:
- SI
- Value:
- 1.32
- Test group / Remarks:
- 2.5 % concentration w/w
- Key result
- Parameter:
- SI
- Value:
- 1.13
- Test group / Remarks:
- 5 % concentration w/w
- Key result
- Parameter:
- SI
- Value:
- 1.15
- Test group / Remarks:
- 10 % w/w concentration
- Interpretation of results:
- not sensitising
- Conclusions:
- The test material was considered to be a non sensitiser under the conditions of the test.
- Executive summary:
Introduction:
A study was performed to assess the skin sensitisation potential of the test material in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The method was designed to meet the requirements of the following:
- OECD Guideline for the Testing of Chemicals No. 429 "Skin Sensitisation: Local Lymph Node Assay" (adopted 24 April 2002)
- Method B42 Skin Sensitisation (Local Lymph Node Assay) of Commission Directive 2004/73/EC.
Methods:
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 10% w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µl (25 µl per ear) of the test material as a solution in 1% pluronic L92 in distilled water at concentrations of 10%, 5% or 2.5% w/w. A further group of four animals was treated with 1% pluronic L92 in distilled water alone.
Results:
The Stimulation Index expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration (%w/w) in
1% pluronic L92 in distilled waterStimulation Index
Result
2.5
1.32
Negative
5
1.13
Negative
10
1.15
Negative
Conclusion:
The test material was considered to be a non‑sensitiser under the conditions of the test.
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study conducted on read-across material
- Justification for type of information:
- A RAAF report will shortly be provided.
- Reason / purpose for cross-reference:
- read-across source
- Type of study:
- mouse local lymph node assay (LLNA)
- Key result
- Parameter:
- SI
- Value:
- 1.32
- Test group / Remarks:
- 2.5 % concentration w/w
- Key result
- Parameter:
- SI
- Value:
- 1.13
- Test group / Remarks:
- 5 % concentration w/w
- Key result
- Parameter:
- SI
- Value:
- 1.15
- Test group / Remarks:
- 10 % concentration w/w
Referenceopen allclose all
Preliminary Screening Test:
Table 1: Clinical observations, bodyweight and mortality data
Concentration (%w/w) in |
Animal Number |
Bodyweight (g) |
Day |
|||||||||
1 |
2 |
3 |
4 |
5 |
6 |
|||||||
Day 1 |
Day 6 |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
Pre-Dose |
Post Dose |
|||||
10 |
S-1 |
17 |
17 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0= No signs of systemic toxicity
Based on this information the dose levels selected for the main test were 10%, 5% and 2.5% w/w in 1% pluronic L92 in distilled water.
Main Test:
Estimation of the Proliferative Response of Lymph Node Cells:
The radioactive disintegrations per minute per lymph node and the stimulation index are given in Table 1 of attachment 1.
A stimulation index of less than 3 was recorded for the three concentrations of the test material (10%, 5% and 2.5% w/win 1% pluronic L92 in distilled water).
Clinical Observations and Mortality Data:
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.
Bodyweight:
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period except for one animal treated with the test material at a concentration of 5% w/w in1 % pluronic L92 in distilled water which showed a slightly higher than expected bodyweight loss.
Table 2: Table to Show Disintegrations per Minute, Disintegrations per Minute/Node and Stimulation Index
Concentration (% w/w) in 1 % pluronic L92 in distilled water |
dpm |
dpm/Node^a |
Stimulation Index^b |
Result |
Vehicle |
3441.01 |
430.13 |
N/A |
N/A |
2.5 |
4551.80 |
568.98 |
1.32 |
Negative |
5 |
3886.80 |
485.85 |
1.13 |
Negative |
10 |
3955.41 |
494.43 |
1.15 |
Negative |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The key study (Bradshaw 2009) was performed to assess the skin sensitisation potential of the read-across material in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The study was conducted in accordance with the standardised guidelines OECD 429 and EU Method B.42 under GLP conditions. The study was therefore assigned a reliability score of 1 in accordance with the criteria for assessing data quality as described in Klimisch et al. (1997).
Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 10 % w/w, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50 µL (25 µL per ear) of the test material as a solution in 1 % pluronic L92 in distilled water at concentrations of 10, 5 or 2.5 % w/w. A further group of four animals was treated with 1 % pluronic L92 in distilled water alone.
The Stimulation Index, expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group, was 1.32, 1.13 and 1.15 at 2.5, 5 and 10 % w/w. these values all indicate a negative result.
The test material was considered to be a non-sensitiser under the conditions of the test.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No. 1272/2008, the substance does not require classification with respect to skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.